ACTIVE COMPOUNDS PREDICTION OF CABE JAMU (PIPER RETROFRACTUM) AS ANTI DIABETIC AGENT
Abstract
Diabetes mellitus is a metabolic disorder disease which is the fourth leading cause of death in Indonesia. The number of people with diabetes in Indonesia shows an increase from year to year, in 2007 people with diabetes reached 14.7% of the population and it is predicted that in 2030 the number of people with diabetes in Indonesia will reach 21.3 million people. Globally, Indonesia ranks fourth in the number of diabetics after India, China and the United States. Herbal medicines from spices have the opportunity to be developed into antidiabetic agents, with considerations of safety, minimal side effects and cheap. Several types of spices have been reported to be used as antidiabetic agents. Cabe jamu, one of the famous spices in Madura, has been reported to have many health benefits. This study will identify the active compounds in cabe jamu that have the ability as antidiabetics by using a molecular docking approach. The results of the study found that cabe jamu has 22 active compounds that have the potential as herbal medicines. Of the 22 active compounds, 10 of them were successfully docked with diabetes aldose reductase protein. The results of this study indicate that the active compounds contained in cabe jamu have the ability as an antidiabetic agent. Based on the strength of the hidrogen bond, and the absence of toxic potential, 3 active compounds from cabe jamu that have strong antidiabetic abilities and no toxic potential were obtained, namely piperine, retrofractamide C, and guineensine.
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Fatimah, R.N. 2015. Diabetes Mellitus Tipe 2. Majority. 4(5): 93–101.
Gumantara, M.P.B. dan Oktarlina. 2017.Perbandingan Monoterapi dan Kombinasi Terapi Sulfonilurea-Metformin terhadap
Pasien Diabetes Melitus Tipe 2. Mojority. 6(1): 55-59.
Hartogh, D.J.D., Gabriel, A. and Tsiani, E. 2020. Antidiabetic Properties of Curcumin II: Evidence from In Vivo Studies. Nutrients. 12(1):58.
Kurniawan, D.A. 2020. Flavonoid Pada Buah Jengkol sebagai Terapi Alternatif Diabetes Melitus Tipe 2. Wellmess and Healthy
Magazine. 2(2): 375-382.
Kurniawati, M. dan Afriadi, A. 2019. Penggunaan Obat pada Pasien Diabetes Mellitus Tipe II Rawat Jalan di Rumah Sakit Umum Haji Medan. Jurnal Dunia Farmasi. 1(3): 101-107.
Rastini, M.B.O., Giantari, N.K.M., Adnyani, K.D. dan Laksmiani, N.P.L. 2019. Molecular Docking Aktivitas Antikanker dari
Quercetin terhadap Kanker Payudara secara Insilico. Jurnal Kimia, 180.
Sakika, K.A., Hanwar, D., Suhendi, A., Kusumowati, I.T.D., dan Santoso, B. 2014. Aktivitas Antidiabetes Ekstrak Etanol
Rimpang Lempuyang Emprit (Zingiber amaricans Bl) pada Tikus Putih yang Diinduksi Aloksan. Prosiding Seminar Nasional Perkembangan Terbaru Pemanfaatan Herbal sebagai Agen
Preventif pada Terapi Kanker, Universitas Wahid Hasyim, Semarang, September 2014, 5-9.
Prasetiyo, A., Mumpuni, E. dan Tjandrawinata, R. 2019. Docking Molekular dari Trigonella foenum-graceum sebagai Antidiabetes
menggunakan Molegro Virtual Docking. Jurnal Jamu Indonesia. 4(2): 74-80.
Riwu, M., Subarnas, A. and Lestari K. 2015. The Correlation of Age Factor, Administration and Metformin Dose Againts Risk of Side Effect on Type 2 Diabetes Mellitus. Indonesian Journal of Clinical Pharmacy. 43(3):151-161.
Xia X. 2017. Bioinformatics and Drug Discovery. Curr Top Med Chem. 17(15): 1709–1726.
DOI
https://doi.org/10.21107/agrointek.v15i4.12317Metrics
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Cahyo Indarto, Supriyanto Supriyanto
This work is licensed under a Creative Commons Attribution 4.0 International License.